Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

SRPTSRPT
6 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in SAREPTA THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.1M shares of SRPT (SAREPTA THERAPEUTICS INC), worth $23.5M as of 2026-Q1. The position was increased (+91.3% shares). SRPT represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$23.5M

Current Shares

1.1M

Total Value Change

-$34.5M

Total Shares Change

+601,186

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Increased
1.1M
+91.3%
$23.5M0.0%$15.87
45
2025-Q4
Increased
563,486
+218.1%
$12.1M0.0%$21.49
45
2025-Q3
Decreased
177,151
-52.9%
$3.4M0.0%$18.82
0
2025-Q2
Increased
376,284
+106.7%
$6.4M0.0%$17.11
44
2025-Q1
Decreased
182,075
-61.8%
$11.6M0.0%$70.41
0
2024-Q4
New
477,066
-
$58M0.0%$121.19
41

Other major holders of SRPT: BlackRock Finance, Inc., BlackRock, Inc., Capital Research Global Investors, VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used